An online database, required by the recent health care law, provides a detailed look at the payments health care professionals receive from drug and medical device companies and is part of a broader push for transparency. Proponents say such disclosures are an important tool to help limit drug and device makers’ influence on doctors, but the website is being questioned by the industry, which says that technical problems and data inaccuracies limit its value. Reisa Sperling, professor of neurology at Brigham and Women’s Hospital, is mentioned.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure